These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5333196)

  • 21. [Complete and incomplete antibodies in urinary tract infections of the child].
    Sietzen W; Knothe H; Kienitz M
    Dtsch Med Wochenschr; 1973 Apr; 98(17):904-5. PubMed ID: 4571887
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response of dogs to experimental infection of bladder pouch.
    Darwish ME; Staubitz WJ; Scheuller EF; Rubin MI; Neter E
    Invest Urol; 1968 Jul; 6(1):66-72. PubMed ID: 4874296
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.
    Schilling JD; Mulvey MA; Hultgren SJ
    J Infect Dis; 2001 Mar; 183 Suppl 1():S36-40. PubMed ID: 11171011
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum precipitins to Escherichia coli in urinary tract and pyogenic infections.
    Sarvamangala Devi JN; Shivananda PG; Venugopal P; Suvarchala M
    Indian J Med Res; 1982 Jun; 75():786-90. PubMed ID: 6752010
    [No Abstract]   [Full Text] [Related]  

  • 25. [Phagocytic function of neutrophils in patients with rheumatoid arthritis complicated by urinary tract infections].
    Matowicka-Karna J; Wysocka J; Kemona H; Białowas D; Bernacka K; Prokopowicz J
    Przegl Lek; 1989; 46(9):686-9. PubMed ID: 2687953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Big differences in the resistance against urinary tract infections. Knowledge of steering mechanisms is limited].
    Svanborg C
    Lakartidningen; 1994 Sep; 91(38):3369-70. PubMed ID: 7990570
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility of immunodeficient gene-knockout mice to urinary tract infection.
    Jones-Carson J; Balish E; Uehling DT
    J Urol; 1999 Jan; 161(1):338-41. PubMed ID: 10037434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil recruitment and resistance to urinary tract infection.
    Haraoka M; Hang L; Frendéus B; Godaly G; Burdick M; Strieter R; Svanborg C
    J Infect Dis; 1999 Oct; 180(4):1220-9. PubMed ID: 10479151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P fimbria-specific B cell responses in patients with urinary tract infection.
    Kantele A; Möttönen T; Ala-Kaila K; Arvilommi HS
    J Infect Dis; 2003 Dec; 188(12):1885-91. PubMed ID: 14673769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence, lipopolysaccharide and mucosal inflammation.
    Svanborg Edén C; Linder H; de Man P; Mattsby-Baltzer I
    Monogr Allergy; 1988; 24():9-15. PubMed ID: 3283535
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the presence of specific antibodies in urinary tract infections due to enterococci].
    ROEMER GB; MAI K
    Z Hyg Infektionskr; 1961; 147():246-56. PubMed ID: 13742690
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemagglutinin, hemolysin, and bactericidin response of dogs with bladder pouch infection.
    Agarwal MK; Darwish ME; Staubitz WJ; Neter E
    Invest Urol; 1970 Sep; 8(2):153-60. PubMed ID: 4924684
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibody titer in experimental urinary tract infection].
    Prát V; Konicková L; Ritzerfeld W; Losse H
    Zentralbl Bakteriol Orig; 1970; 212(2):512-4. PubMed ID: 4910456
    [No Abstract]   [Full Text] [Related]  

  • 34. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution of induced urinary tract infection: an animal model to assess bladder immunization.
    Jensen J; Balish E; Mizutani K; Uehling DT
    J Urol; 1982 Jun; 127(6):1220-2. PubMed ID: 7045407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenetic aspects of uncomplicated urinary tract infection: recent advances.
    Fünfstück R; Smith JW; Tschäpe H; Stein G
    Clin Nephrol; 1997 Jan; 47(1):13-8. PubMed ID: 9021235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesion inhibition by antibodies.
    Svanborg-Edén C; Mårild S; Korhonen TK
    Scand J Infect Dis Suppl; 1982; 33():72-8. PubMed ID: 6127804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do type 1 fimbriae promote inflammation in the human urinary tract?
    Bergsten G; Wullt B; Schembri MA; Leijonhufvud I; Svanborg C
    Cell Microbiol; 2007 Jul; 9(7):1766-81. PubMed ID: 17359236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current concepts of molecular defence mechanisms operative during urinary tract infection.
    Weichhart T; Haidinger M; Hörl WH; Säemann MD
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic diversity of Escherichia coli and the emergence of 'exotic' islands in the gene stream.
    Dozois CM; Curtiss R
    Vet Res; 1999; 30(2-3):157-79. PubMed ID: 10367353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.